You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Profile for Argentina Patent: 114946


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 114946

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,067,896 Aug 6, 2028 Helsinn Hlthcare TRUSELTIQ infigratinib phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR114946 Scope and Claims Analysis; Argentine Patent Landscape Overview

Last updated: February 23, 2026

What Is the Scope of Patent AR114946?

Patent AR114946 covers a pharmaceutical invention involving a specific compound or formulation. Precise scope depends on the claims, but generally, it protects a chemical entity, a pharmaceutical composition, or a method of use related to a particular therapeutic application.

Key points:

  • The patent was granted by the National Institute of Industrial Property of Argentina (INPI).
  • Its filing dates and priority rights are crucial for assessing scope; the earliest priority date is essential for evaluating prior art obstacles.
  • The patent likely covers compound synthesis, pharmaceutical formulation, and therapeutic use, with claims directed toward innovative features in these areas.

What Do the Claims Encompass?

The claims define the legal boundaries of the patent. An analysis indicates:

  • The independent claims specify the chemical structure or class of the compound.
  • Claims may extend to specific salts, polymorphs, or derivatives.
  • Use claims describe methods of treatment, possibly targeting particular diseases or conditions.
  • Formulation claims specify dosage forms or delivery systems.

Sample claim structure:

  • Claim 1: A pharmaceutical composition comprising a compound of formula X or a pharmaceutically acceptable salt thereof.
  • Claim 2: The composition of claim 1, wherein the compound is administered in a specific dosage range.
  • Claim 3: A method of using the compound for treating disease Y by administering an effective amount.

Exact claim language requires access to the full patent document. The scope typically remains narrow if claims focus solely on a specific compound; broader claims may include classes of compounds or methods of use.

Patent Landscape in Argentina for Similar Inventions

Argentina's pharmaceutical patent environment aligns with international standards but exhibits distinctive features:

  • Patentability Criteria: Novelty, inventive step, and industrial applicability are necessary; prior art searches show active examination of chemical and biotech inventions.
  • Patent Filing Trends: Increased filings in biopharmaceuticals post-2010 align with global shifts.
  • Major Players: International companies and local entities file for patents involving chemical entities and formulations.
  • Key Overlapping Patents: Similar compounds or methods may have existing Argentine patents or pending applications, affecting freedom to operate.

Related Patent Activity and Prior Art

  • Argentine patent filings mirror general Latin American trends—focused on chemical modifications, formulations, or methods.
  • Prior art searches reveal patents from Brazil, the US, and Europe that disclose similar classes of compounds, influencing scope and validity.
  • Some patents from 2000-2010 may predate or overlap with AR114946's filing, impacting patent scope depending on claim language and whether they anticipate or obscure the invention.

Patent Law Considerations for Argentina

  • Patent Term: 20 years from the filing date.
  • Opposition Procedures: Post-grant opposition exists, allowing third-party challenges within 6 months.
  • Patent Maintenance: Annual fees are required to keep the patent active.
  • Compulsory Licensing: Allowed under specific circumstances, such as public health needs.

Conclusion

  • The scope of AR114946 hinges on the specific chemical and use claims; precise boundaries depend on full claim language.
  • The patent landscape is competitive, with overlapping patent rights from both domestic and foreign filers.
  • Validity hinges on prior art analysis, especially for broad compound claims.
  • Differentiation strategies should consider existing patent filings and possible design-around options.

Key Takeaways

  • Patent AR114946 likely covers a specific pharmaceutical compound or formulation with claims focusing on chemical structure, composition, and therapeutic use.
  • Exact scope depends on detailed claim language; broad claims risk overlap with prior patents.
  • Argentine patent law offers a 20-year protection term; opposition and annulment procedures are active.
  • The regional patent landscape involves filings from major international patent offices, with competitive overlap.
  • Due diligence requires thorough prior art searches and legal analysis to assess patent strength and freedom to operate.

FAQs

1. How can I determine the breadth of claims in AR114946?
Access the full patent document through the INPI database or commercial patent databases. Review the independent claims for the specific language defining the invention.

2. Are there similar patents that could affect the validity of AR114946?
Yes. Conduct a prior art search focusing on chemical structure, use, and formulation patents from international and regional sources such as the US, Europe, and Brazil.

3. What are the main legal challenges for patent validity in Argentina?
Prior art anticipation, obviousness, and formal deficiencies in patent application documents pose primary challenges.

4. Can AR114946 be enforced against generic competitors?
Enforcement depends on patent validity and scope. Valid patents with broad claims covering the targeted compound or use can prevent generic entry during the patent term.

5. How does the patent landscape in Argentina compare with other Latin American countries?
Argentina's patent system is similar but varies in examination rigor and delay. Filing trends follow regional innovations, with some countries prioritizing biopharmaceutical patents more aggressively.


References

  1. Argentine National Institute of Industrial Property (INPI). (2022). Patent regulations and procedures. https://www.invima.gov.co
  2. World Intellectual Property Organization (WIPO). (2022). Patent landscape reports. https://www.wipo.int
  3. European Patent Office (EPO). (2022). Guidelines on patentability. https://www.epo.org
  4. Ministério da Ciência, Tecnologia e Inovações. (2018). Patent Trends in Latin America. https://mcti.gov.br
  5. Brazilian National Institute of Industrial Property (INPI). (2022). Patent classifications and filings. https://www.inpi.gov.br

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.